Marko Bukur

Marko Bukur

Auto-generated profile, based on publicly available information

Marko Bukur

Department of Surgery, New York University School of Medicine, New York, New York

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2012 in Injury
Verified
Journal Article
Closed access
CBCherisse Berry
Cherisse Berry
ELEric J. Ley
Eric J. Ley
MBMarko Bukur
Marko Bukur
DMDarren Malinoski
Darren Malinoski
DMDaniel R. Margulies
Daniel R. Margulies
ASAli Salim
Ali Salim

11 November 2019 in Injury Prevention
Verified
Journal Article
Closed access
PDF file
CDCharles J DiMaggio
Charles J DiMaggio
MBMarko Bukur
Marko Bukur
SWStephen Wall
Stephen Wall
SFSpiros G Frangos
Spiros G Frangos
AWAndy Y Wen
Andy Y Wen
Background Powered, two-wheeled transportation devices like electric bicycles (E-bikes) and scooters are increasingly popular, but little is known about their relative injury risk compared to pedal operated bicycles. Methods Descriptive and comparative analysis of injury patterns and trends associated with E-bikes, powered scooters and pedal bicycles from 2000 to 2017 using the US National Electronic Injury Surveillance System. Results While persons injured using E-bikes were more likely to suffer internal injuries (17.1%; 95% CI 5.6 to 28.6) and require hospital admission (OR=2.8, 95% CI 1.3 to 6.1), powered scooter injuries were nearly three times more likely to result in a diagnosis of concussion (3% of scooter injuries vs 0.5% of E-bike injuries). E-bike-related injuries were also more than three times more likely to involve a collision with a pedestrian than either pedal bicycles (OR=3.3, 95% CI 0.5 to 23.6) or powered scooters (OR=3.3, 95% CI 0.3 to 32.9), but there was no evidence that powered scooters were more likely than bicycles to be involved in a collision with a pedestrian (OR=1.0, 95% CI 0.3 to 3.1). While population-based rates of pedal bicycle-related injuries have been decreasing, particularly among children, reported E-bike injuries have been increasing dramatically particularly among older persons. Conclusions E-bike and powered scooter use and injury patterns differ from more traditional pedal operated bicycles. Efforts to address injury prevention and control are warranted, and further studies examining demographics and hospital resource utilisation are necessary.

1 May 2017 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Closed access
PDF file
LKLeslie Kobayashi
Leslie Kobayashi
GBGalinos Barmparas
Galinos Barmparas
PBPatrick Bosarge
Patrick Bosarge
CBCarlos V. Brown
Carlos V. Brown
MBMarko Bukur
Marko Bukur
RCRaul Coimbra
Raul Coimbra
The number of anticoagulated trauma patients is increasing. Trauma patients on warfarin have been found to have poor outcomes, particularly after intracranial hemorrhage (ICH). However, the effect of novel oral anticoagulants (NOAs) on trauma outcomes is unknown. We hypothesized that patients on NOAs would have higher rates of ICH, ICH progression, and death compared with patients on traditional anticoagulant and antiplatelet agents. This was a prospective observational trial across 16 trauma centers. Inclusion criteria was any trauma patient admitted on aspirin, clopidogrel, warfarin, dabigatran, rivaroxaban, or apixaban. Demographic data, admission vital signs, mechanism of injury, injury severity scores, laboratory values, and interventions were collected. Outcomes included ICH, progression of ICH, and death. A total of 1,847 patients were enrolled between July 2013 and June 2015. Mean age was 74.9 years (SD ± 13.8), 46% were female, 77% were non-Hispanic white. At least one comorbidity was reported in 94% of patients. Blunt trauma accounted for 99% of patients, and the median Injury Severity Score was 9 (interquartile range, 4–14). 50% of patients were on antiplatelet agents, 33% on warfarin, 10% on NOAs, and 7% on combination therapy or subcutaneous agents. Patients taking NOAs were not at higher risk for ICH on univariate (24% vs. 31%) or multivariate analysis (incidence rate ratio, 0.78; confidence interval 0.61–1.01, p = 0.05). Compared with all other agents, patients on aspirin (90%, 81 mg; 10%, 325 mg) had the highest rate (35%) and risk (incidence rate ratio, 1.27; confidence interval, 1.13–1.43; p < 0.001) of ICH. Progression of ICH occurred in 17% of patients and was not different between medication groups. Study mortality was 7% and was not significantly different between groups on univariate or multivariate analysis. Patients on NOAs were not at higher risk for ICH, ICH progression, or death. Prognostic/epidemiologic study, level III.

1 December 2010 in Journal of Trauma: Injury, Infection & Critical Care
Verified
Journal Article
Closed access
HLHarald Leemann
Harald Leemann
TLThomas Lustenberger
Thomas Lustenberger
PTPeep Talving
Peep Talving
LKLeslie Kobayashi
Leslie Kobayashi
MBMarko Bukur
Marko Bukur
MKMarius J. B. Keel
Marius J. B. Keel
Early prediction of massive transfusion (MT) is critical in the management of severely injured trauma patients. Variables available early after injury including physiologic, laboratory, and rotation thromboelastometric (ROTEM) parameters were evaluated as predictors for the need of MT. After Institutional Review Board approval, we retrospectively reviewed a cohort of severely injured trauma patients (Injury Severity Score ≥ 16) admitted to a Level I trauma center with available ROTEM measurements on hospital admission during a 1-year study period. Patients with isolated head injury (Abbreviated Injury Scale head ≥ 3 and Abbreviated Injury Scale chest, abdomen, and extremity < 3) and patients with a penetrating mechanism of injury were excluded. Patients who received a MT (≥ 10 units packed red blood cell within 24 hours of admission) were compared with patients who did not. Variables independently associated with MT were identified using stepwise logistic regression. A total of 53 patients met inclusion criteria. Of these, 18 patients (34.0%) received a MT and 35 patients (66.0%) did not. Massively transfused patients had significantly lower baseline hemoglobin values (7.9 g/dL ± 0.4 g/dL vs. 11.4 g/dL ± 0.4 g/dL; p < 0.001) and a trend toward higher lactate (4.8 mmol/L ± 0.8 mmol/L vs. 3.0 mmol/L ± 0.3 mmol/L; p = 0.056) and base deficit values (5.9 mmol/L ± 1.1 mmol/L vs. 3.6 mmol/L ± 0.6 mmol/L; p = 0.052). Mean international normalized ratio (1.46 ± 0.07 vs. 1.22 ± 0.05; p = 0.001) and partial thromboplastin times (42.4 seconds ± 5.0 seconds vs. 29.7 seconds ± 1.8 seconds; p < 0.001) were significantly higher in MT patients. Patients receiving a MT had significantly altered ROTEM values on admission compared with non-MT patients. An increase in the clot formation time (471.3 seconds ± 169.9 seconds vs. 178.1 seconds ± 19.9 seconds; p = 0.001), a shortening of the maximum clot firmness (37.5 mm ± 2.9 mm vs. 50.7 mm ± 1.4 mm; p < 0.001), and a shortening of the clot amplitude at all time points (10/20/30 minutes) were observed in massively transfused trauma patients. Variables independently associated with MT included a hemoglobin level ≤ 10 g/dL and an abnormal maximum clot firmness value (area under the receiver operator characteristic curve: 0.831 [95% confidence interval: 0.719-0.942; p < 0.001]). Hemoglobin ≤ 10 g/dL and an abnormal maximum cloth firmness measured by rotation thromboelastometry on admission reliably predict the need for MT. Prospective validation of the effectiveness of thromboelastometry to guide the transfusion practice after trauma is warranted.

1 December 2014 in Journal of Critical Care
Verified
Journal Article
Closed access
GBGalinos Barmparas
Galinos Barmparas
DLDouglas Liou
Douglas Liou
DLDebora Lee
Debora Lee
NFNicole Fierro
Nicole Fierro
MBMatthew Bloom
Matthew Bloom
MBMarko Bukur
Marko Bukur

1 January 2011 in Journal of Trauma: Injury, Infection & Critical Care
Verified
Journal Article
Closed access
BBBernardino C. Branco
Bernardino C. Branco
DPDavid Md Plurad
David Md Plurad
DGDonald J. Md Green
Donald J. Md Green
KIKenji Md Inaba
Kenji Md Inaba
LLLydia Md Lam
Lydia Md Lam
DDDemetrios Demetriades
Demetrios Demetriades
Background: The purpose of this study was to determine the incidence and identify clinical predictors for the need for tracheostomy after cervical spinal cord injury (CSCI). Methods: The National Trauma Databank version 7.0 (2002–2006) was used to identify all patients who sustained a CSCI. Patients with severe traumatic brain injury (TBI) were excluded. Demographics, clinical data, and outcomes were abstracted. Patients requiring tracheostomy were compared with those who did not require tracheostomy. Logistic regression analysis was used to identify independent predictors for the need of tracheostomy. Results: There were 5,265 eligible patients. Of these, 1,082 (20.6%) required tracheostomy and 4,174 (79.4%) did not. The majority patients were men and blunt trauma predominated. Patients requiring tracheostomy had a higher Injury Severity Score (ISS) (33.5 ± 17.7 vs. 24.4 ± 16.2, p < 0.001) and required intubation more frequently on scene and Emergency Department (ED) (4.2 vs. 1.4%, p < 0.001 and 31.1 vs. 7.9%, p < 0.001, respectively). Patients requiring tracheostomy had higher rates of complete CSCI at C1-C4 (18.2 vs. 8.4%, p < 0.001) and C5-C7 levels (37.8 vs. 16.9%, p < 0.001). Patients requiring tracheostomy had more ventilation days, longer intensive care unit and hospital lengths of stay, but lower mortality. Intubation on scene or ED, complete CSCI at C1-C4 or C5-C7 levels, ISS ≥16, facial fracture, and thoracic trauma were identified as independent predictors for the need of tracheostomy. Conclusion: After CSCI, a fifth of patients will require tracheostomy. Intubation on scene or ED, complete CSCI at C1-C4 or C5-C7 levels, ISS ≥16, facial fracture, and thoracic trauma were independently associated with the need for tracheostomy.